MCT1, MCT4 and CD147 expression and 3-bromopyruvate toxicity in colorectal cancer cells are modulated by the extracellular conditions
- PMID: 30699066
- DOI: 10.1515/hsz-2018-0411
MCT1, MCT4 and CD147 expression and 3-bromopyruvate toxicity in colorectal cancer cells are modulated by the extracellular conditions
Abstract
Monocarboxylate transporters (MCTs) inhibition leads to disruption in glycolysis, induces cell death and decreases cell invasion, revealing the importance of MCT activity in intracellular pH homeostasis and tumor aggressiveness. 3-Bromopyruvate (3BP) is an anti-tumor agent, whose uptake occurs via MCTs. It was the aim of this work to unravel the importance of extracellular conditions on the regulation of MCTs and in 3BP activity. HCT-15 was found to be the most sensitive cell line, and also the one that presented the highest basal expression of both MCT1 and of its chaperone CD147. Glucose starvation and hypoxia induced an increased resistance to 3BP in HCT-15 cells, in contrast to what happens with an extracellular acidic pH, where no alterations in 3BP cytotoxicity was observed. However, no association with MCT1, MCT4 and CD147 expression was observed, except for glucose starvation, where a decrease in CD147 (but not of MCT1 and MCT4) was detected. These results show that 3BP cytotoxicity might include other factors beyond MCTs. Nevertheless, treatment with short-chain fatty acids (SCFAs) increased the expression of MCT4 and CD147 as well as the sensitivity of HCT-15 cells to 3BP. The overall results suggest that MCTs influence the 3BP effect, although they are not the only players in its mechanism of action.
Keywords: 3-bromopyruvate; Warburg effect; colorectal cancer; monocarboxylate transporters.
Similar articles
-
CD147 subunit of lactate/H+ symporters MCT1 and hypoxia-inducible MCT4 is critical for energetics and growth of glycolytic tumors.Proc Natl Acad Sci U S A. 2011 Oct 4;108(40):16663-8. doi: 10.1073/pnas.1106123108. Epub 2011 Sep 19. Proc Natl Acad Sci U S A. 2011. PMID: 21930917 Free PMC article.
-
The cytotoxicity of 3-bromopyruvate in breast cancer cells depends on extracellular pH.Biochem J. 2015 Apr 15;467(2):247-58. doi: 10.1042/BJ20140921. Biochem J. 2015. PMID: 25641640
-
Expression of monocarboxylate transporters 1, 2, and 4 in human tumours and their association with CD147 and CD44.J Biomed Biotechnol. 2010;2010:427694. doi: 10.1155/2010/427694. Epub 2010 May 4. J Biomed Biotechnol. 2010. PMID: 20454640 Free PMC article.
-
The altered glucose metabolism in tumor and a tumor acidic microenvironment associated with extracellular matrix metalloproteinase inducer and monocarboxylate transporters.Oncotarget. 2016 Apr 26;7(17):23141-55. doi: 10.18632/oncotarget.8153. Oncotarget. 2016. PMID: 27009812 Free PMC article. Review.
-
Monocarboxylate transporter 1 and 4 inhibitors as potential therapeutics for treating solid tumours: A review with structure-activity relationship insights.Eur J Med Chem. 2020 Aug 1;199:112393. doi: 10.1016/j.ejmech.2020.112393. Epub 2020 May 1. Eur J Med Chem. 2020. PMID: 32388280 Review.
Cited by
-
pH Homeodynamics and Male Fertility: A Coordinated Regulation of Acid-Based Balance during Sperm Journey to Fertilization.Biomolecules. 2024 Jun 12;14(6):685. doi: 10.3390/biom14060685. Biomolecules. 2024. PMID: 38927088 Free PMC article. Review.
-
The efficacy of the anticancer 3-bromopyruvate is potentiated by antimycin and menadione by unbalancing mitochondrial ROS production and disposal in U118 glioblastoma cells.Heliyon. 2020 Dec 19;6(12):e05741. doi: 10.1016/j.heliyon.2020.e05741. eCollection 2020 Dec. Heliyon. 2020. PMID: 33364504 Free PMC article.
-
Glycolytic Inhibitors Potentiated the Activity of Paclitaxel and Their Nanoencapsulation Increased Their Delivery in a Lung Cancer Model.Pharmaceutics. 2022 Sep 23;14(10):2021. doi: 10.3390/pharmaceutics14102021. Pharmaceutics. 2022. PMID: 36297455 Free PMC article.
-
Psychological Stress Up-Regulates CD147 Expression Through Beta-Arrestin1/ERK to Promote Proliferation and Invasiveness of Glioma Cells.Front Oncol. 2020 Oct 15;10:571181. doi: 10.3389/fonc.2020.571181. eCollection 2020. Front Oncol. 2020. PMID: 33178600 Free PMC article.
-
Histone lactylation bridges metabolic reprogramming and epigenetic rewiring in driving carcinogenesis: Oncometabolite fuels oncogenic transcription.Clin Transl Med. 2024 Mar;14(3):e1614. doi: 10.1002/ctm2.1614. Clin Transl Med. 2024. PMID: 38456209 Free PMC article. Review.
References
-
- Al Okail, M.S. (2010). Cobalt chloride, a chemical inducer of hypoxia-inducible factor-1α in U251 human glioblastoma cell line. J. Saudi Chem. Soc. 14, 197–201.
-
- Azevedo-Silva, J., Queirós, O., Ribeiro, A., Baltazar, F., Young, K.H., Pedersen, P.L., Preto, A., and Casal, M. (2015). The cytotoxicity of 3-bromopyruvate in breast cancer cells depends on extracellular pH. Biochem. J. 467, 247–258.
-
- Azevedo-Silva, J., Queirós, O., Baltazar, F., Ułaszewski, S., Goffeau, A., Ko, Y.H., Pedersen, P.L., Preto, A., and Casal, M. (2016). The anticancer agent 3-bromopyruvate: a simple but powerful molecule taken from the lab to the bedside. J. Bioenerg. Biomembr. 48, 349–362.
-
- Bao, W., Chen, M., Zhao, X., Kumar, R., Spinnler, C., Thullberg, M., Issaeva, N., Selivanova, G., and Stromblad, S. (2011). PRIMA-1Met/APR-246 induces wild-type p53-dependent suppression of malignant melanoma tumor growth in 3D culture and in vivo. Cell Cycle 10, 301–307.
-
- Berg, K.C.G., Eide, P.W., Eilertsen, I.A., Johannessen, B., Bruun, J., Danielsen, S.A., Bjornslett, M., Meza-Zepeda, A., Eknaes, M., Lind, G.E., et al. (2017). Multi-omics of 34 colorectal cancer cell lines – a resource for biomedical studies. Mol. Cancer 116, 1–16.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous